Compare CLNN & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLNN | TPCS |
|---|---|---|
| Founded | 2012 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.4M | 54.0M |
| IPO Year | 2021 | 2008 |
| Metric | CLNN | TPCS |
|---|---|---|
| Price | $3.86 | $5.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.20 | N/A |
| AVG Volume (30 Days) | ★ 121.9K | 17.7K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.38 |
| EPS | N/A | ★ N/A |
| Revenue | $200,000.00 | ★ $31,644,000.00 |
| Revenue This Year | $24.70 | N/A |
| Revenue Next Year | $9,228.71 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.25 | $2.88 |
| 52 Week High | $13.50 | $6.31 |
| Indicator | CLNN | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 42.32 | 66.57 |
| Support Level | $3.25 | $5.11 |
| Resistance Level | $4.70 | $6.31 |
| Average True Range (ATR) | 0.27 | 0.17 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 15.16 | 90.51 |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.